共 50 条
Long-term safety of dupilumab in patients with moderate-to-severe asthma who completed the liberty asthma traverse continuation study
被引:0
|作者:
Maspero, J.
[1
]
Peters, A.
[2
]
Chapman, K.
[3
]
Domingo, C.
[4
]
Stewart, J.
[5
]
Hardin, M.
[6
]
Maroni, J.
[7
]
Tawo, K.
[8
]
Khokhar, F. A.
[7
]
Mortenson, E.
[7
]
Laws, E.
[8
]
Amr, R.
[7
]
Jacob-Nara, J. A.
[8
]
Deniz, Y.
[7
]
Rowe, P. J.
[8
]
机构:
[1] Fdn Cidea, Buenos Aires, DF, Argentina
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[3] Univ Toronto, Toronto, ON, Canada
[4] Autonomous Univ Barcelona, Corporacio Sanitaria Parc Tauli Sabadell, Barcelona, Spain
[5] Sanofi, Montreal, PQ, Canada
[6] Sanofi, Cambridge, MA USA
[7] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[8] Sanofi, Bridgewater, MA USA
来源:
关键词:
D O I:
暂无
中图分类号:
R392 [医学免疫学];
学科分类号:
100102 ;
摘要:
000186
引用
收藏
页码:188 / 189
页数:2
相关论文